ADRB1 | Adrenoceptor beta 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf170 | Chromosome 1 open reading frame 170 | | | | | | Tissue enhanced |
C1QTNF9 | C1q and tumor necrosis factor related protein 9 | Predicted secreted proteins
| | | | | Tissue enhanced |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
CDH13 | Cadherin 13 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLGN | Calmegin | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
FILIP1 | Filamin A interacting protein 1 | | | | | | Tissue enhanced |
HSPB2-C11orf52 | HSPB2-C11orf52 readthrough (NMD candidate) | | | | | | Tissue enhanced |
HSPB8 | Heat shock 22kDa protein 8 | Disease related genes
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
NDRG4 | NDRG family member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
NEBL | Nebulette | | | | | | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PLN | Phospholamban | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins
| | | | | Tissue enhanced |
RAB9B | RAB9B, member RAS oncogene family | Predicted secreted proteins
| | | | | Tissue enhanced |
RP11-849F2.7 | KRAB-A domain-containing protein 2 | | | | | | Tissue enhanced |
RRAD | Ras-related associated with diabetes | | | | | | Tissue enhanced |
SGSM1 | Small G protein signaling modulator 1 | | | | | | Tissue enhanced |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC8A1 | Solute carrier family 8 (sodium/calcium exchanger), member 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SORBS2 | Sorbin and SH3 domain containing 2 | | | | | | Tissue enhanced |
SYNDIG1 | Synapse differentiation inducing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
SYNPO | Synaptopodin | | | | | | Tissue enhanced |
TCF15 | Transcription factor 15 (basic helix-loop-helix) | Transcription factors
| | | | | Tissue enhanced |
TSPAN9 | Tetraspanin 9 | Predicted membrane proteins
| | | | | Tissue enhanced |